{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:27:52Z","timestamp":1787041672586,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304372"],"award-info":[{"award-number":["82304372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["2025CXPT012"],"award-info":[{"award-number":["2025CXPT012"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["2024CXPT029"],"award-info":[{"award-number":["2024CXPT029"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119101","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:24:15Z","timestamp":1782851055000},"page":"119101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of novel ROCK inhibitors RX-021 and RX-044 with intraocular pressure-lowering effect for glaucoma treatment"],"prefix":"10.1016","volume":"317","author":[{"given":"Guiyan","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rilei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangjian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119101_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/joph\/8476785","article-title":"Exploring glaucoma: from pathogenesis to emerging diagnostic and management strategies","volume":"2025","author":"Goit","year":"2025","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.ejmech.2026.119101_bib2","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","article-title":"Glaucoma: now and beyond","volume":"402","author":"Jayaram","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119101_bib3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/s44161-025-00704-3","article-title":"Human ocular fluid outflow on-chip reveals trabecular meshwork-mediated schlemm's canal endothelial dysfunction in steroid-induced glaucoma","volume":"4","author":"Lu","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.ejmech.2026.119101_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/bs.pmbts.2015.06.007","article-title":"Intraocular pressure and the mechanisms involved in resistance of the aqueous humor flow in the trabecular meshwork outflow pathways","volume":"134","author":"Tamm","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.ejmech.2026.119101_bib5","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3390\/biomedicines12092000","article-title":"Glaucoma: current and new therapeutic approaches","volume":"12","author":"Lee","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2026.119101_bib6","doi-asserted-by":"crossref","first-page":"10533","DOI":"10.1021\/acs.jmedchem.9b01033","article-title":"Ocular disease therapeutics: design and delivery of drugs for diseases of the eye","volume":"63","author":"Cheng","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119101_bib7","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1021\/acs.jmedchem.2c01753","article-title":"Application and study of ROCK inhibitors in pulmonary fibrosis: recent developments and future perspectives","volume":"66","author":"Xie","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119101_bib8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/0113894501286195231220094646","article-title":"Rho kinase (ROCK) inhibitors for the treatment of glaucoma","volume":"25","author":"Wu","year":"2024","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejmech.2026.119101_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108336","article-title":"ROCK inhibitor: focus on recent updates","volume":"34","author":"You","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119101_bib10","doi-asserted-by":"crossref","DOI":"10.53941\/ijddp.2025.100018","article-title":"Rho\/ROCK pathway as a therapeutic target in multiple diseases","volume":"4","author":"Cheng","year":"2025","journal-title":"Int J Drug Discov Pharm"},{"key":"10.1016\/j.ejmech.2026.119101_bib11","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.survophthal.2025.03.008","article-title":"Exploring the potential of rho kinase inhibitors in ophthalmology: from mechanisms to clinical practice","volume":"70","author":"Tan","year":"2025","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejmech.2026.119101_bib12","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1038\/s41433-024-03342-4","article-title":"Ocular effects of rho kinase (ROCK) inhibition: a systematic review","volume":"38","author":"Lin","year":"2024","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ejmech.2026.119101_bib13","doi-asserted-by":"crossref","first-page":"e676","DOI":"10.1097\/MJT.0000000000000362","article-title":"The ocular hypotensive efficacy of topical fasudil, a rho-associated protein kinase inhibitor, in patients with end-stage glaucoma","volume":"24","author":"Pakravan","year":"2017","journal-title":"Am. J. Therapeut."},{"key":"10.1016\/j.ejmech.2026.119101_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/srep19640","article-title":"Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells","volume":"6","author":"Kaneko","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119101_bib15","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.1167\/iovs.13-13842","article-title":"The novel rho kinase (ROCK) inhibitor K-115: a new candidate drug for neuroprotective treatment in glaucoma","volume":"55","author":"Yamamoto","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejmech.2026.119101_bib16","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.bmcl.2016.03.104","article-title":"Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma","volume":"26","author":"Sturdivant","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119101_bib17","article-title":"Comparative efficacy and safety of netarsudil-containing interventions for intraocular pressure control: a systematic review and network meta-analysis","volume":"17","author":"Awan","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.ejmech.2026.119101_bib18","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1200\/JCO.20.02754","article-title":"ROCK2 inhibition with belumosudil (KD025) for the treatment of chronic graft-versus-host disease","volume":"39","author":"Jagasia","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119101_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/13543784.2025.2510667","article-title":"Role of ROCK2 inhibitors in the treatment of chronic graft-versus-host disease","volume":"34","author":"Ngo","year":"2025","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2026.119101_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1124\/jpet.106.110635","article-title":"Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities","volume":"320","author":"Doe","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2026.119101_bib21","doi-asserted-by":"crossref","first-page":"10008","DOI":"10.1021\/acs.jmedchem.4c03047","article-title":"Design, synthesis, and evaluation of novel ROCK inhibitors for glaucoma treatment: insights into in vitro and in vivo efficacy and safety","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119101_bib22","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1021\/acs.jmedchem.3c02441","article-title":"Discovery of D25, a potent and selective MNK inhibitor for sepsis-associated acute spleen injury","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119101_bib23","doi-asserted-by":"crossref","first-page":"1916380","DOI":"10.1080\/21688370.2021.1916380","article-title":"MRCK: a master regulator of tissue remodeling or another \u2032ROCK' in the epithelial block","volume":"9","author":"Zihni","year":"2021","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.ejmech.2026.119101_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12938-016-0254-2","article-title":"Microstructure visualization of conventional outflow pathway and finite element modeling analysis of trabecular meshwork","volume":"15","author":"Zhang","year":"2016","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.ejmech.2026.119101_bib25","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3390\/biom11091258","article-title":"Cell-based therapies for trabecular meshwork regeneration to treat glaucoma","volume":"11","author":"Mallick","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.119101_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.trecan.2022.12.001","article-title":"Preclinical to clinical utility of ROCK inhibitors in cancer","volume":"9","author":"Barcelo","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ejmech.2026.119101_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2026.104109","article-title":"ROCK signaling at the crossroads of redox stress, mitochondrial dynamics, and metabolic disease","volume":"92","author":"Nagai","year":"2026","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2026.119101_bib28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41419-023-05642-1","article-title":"Rho A\/ROCK1 signaling-mediated metabolic reprogramming of valvular interstitial cells toward warburg effect accelerates aortic valve calcification via AMPK\/RUNX2 axis","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119101_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","article-title":"AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance","volume":"66","author":"Garcia","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2026.119101_bib30","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2147\/DDDT.S515166","article-title":"Rho kinase inhibitors in glaucoma management: current perspectives and future directions","volume":"19","author":"Chatzimichail","year":"2025","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2026.119101_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","article-title":"ISCEV standard for full-field clinical electroretinography (2022 update)","volume":"144","author":"Robson","year":"2022","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.ejmech.2026.119101_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.procbio.2023.09.022","article-title":"Unraveling the mechanistic details of rho-associated coiled-coil kinase1 (ROCK1) inhibition: implications from pharmacophore mapping and free energy analysis","volume":"134","author":"Gupta","year":"2023","journal-title":"Process Biochem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:03:31Z","timestamp":1787040211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":32,"alternative-id":["S0223523426005465"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119101","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel ROCK inhibitors RX-021 and RX-044 with intraocular pressure-lowering effect for glaucoma treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119101"}}